Akoya Biosciences and Enable Medicine introduce new cloud platform
The new platform has been designed to enable faster analysis of PhenoCycler-Fusion data
17 Apr 2023
Akoya Biosciences, Inc., in partnership with Enable Medicine, will introduce the Enable Cloud Platform at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Florida, USA. Available as software-as-a-solution (SaaS) package for PhenoCycler-Fusion users, the Enable Cloud Platform is an end-to-end spatial cloud solution for data management, image analysis, and mapping predictive spatial signatures.
Available as software-as-a-solution (SaaS) package for PhenoCycler-Fusion users, the Enable Cloud Platform is an end-to-end spatial cloud solution for data management, image analysis, and mapping predictive spatial signatures.
The Enable Cloud Platform has been optimized on more than 20,000 samples run on the PhenoCycler platform and is an ideal cloud solution for large spatial imaging datasets. Powered by the Enable Atlas database and an intuitive, biologist-friendly user interface, the platform is designed to help researchers go from phenotypes to insights in minutes instead of days or weeks.
